Racial/ethnic differences in patients with anemia and folate deficiencyMiguel González-Vélez, Leslie Padrnos, Carolyn Mead‐Harvey et al.|International Journal of Laboratory Hematology|2020Cited by 17
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patientsRodrigo Fonseca, Rafaël Fonseca, Miguel González-Vélez et al.|Research Square|2022Cited by 3
Clinical outcomes of abiraterone acetate + prednisone (AA) + bone resorption inhibitors (BRI) versus AA alone as first-line therapy for castration-resistant prostate cancer (CRPC) with bone metastases (BM) in an international multicenter database.Edoardo Francini, Daniel Yick Chin Heng, Francesca Montagnani et al.|Journal of Clinical Oncology|2020Cited by 1
Efficacy of bone resorption inhibitors (BRI) + abiraterone acetate + prednisone (AA) vs. AA alone as first-line therapy for men with castration-resistant prostate cancer (CRPC) and bone metastases (BM) in an international multicenter hospital-based registry.Edoardo Francini, Daniel Yick Chin Heng, Francesca Montagnani et al.|Journal of Clinical Oncology|2019Cited by 0
An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and EfficacyAdrienne Kaufman, Leslie Padrnos, Yael Kusne et al.|Blood|2021Cited by 0